Takeda’s Post

Big news in the pharma world! 🌐 Giovanni Caforio, ex-CEO at Bristol Myers, is gearing up to chair the board at Novartis in 2024. Joerg Reinhardt's passing the torch after a transformative decade. Think this move could stir innovation in MedTech? Or maybe it's just the leadership shake-up needed for groundbreaking healthcare solutions. Partnering with many executives, c-suite champions, and company leadership teams, we know the value of fresh perspectives at the helm. 👓🔀 Looking to lead tech teams in MedTech or HealthTech? Or perhaps looking to add that game-changer to your companies leadership structure? Let's chat about shaping the future of healthcare through executive talent. #TechTalent #MedtechInnovation #LeadershipHiring

#𝗧𝗲𝘃𝗮𝗧𝗵𝗲𝗻𝗔𝗻𝗱𝗡𝗼𝘄: 𝗘𝗺𝗯𝗿𝗮𝗰𝗶𝗻𝗴 𝗗𝗶𝘃𝗲𝗿𝘀𝗶𝘁𝘆 Since the very beginning, Teva took pride in its people and culture, embracing the creativity that comes with different perspectives and dialogue. In today’s rapidly evolving landscape of medicine development, diversity has become a key driver of innovation. Earlier this year, we sat down with three inspiring leaders from Teva R&D – Heather De Luca, Head of Global Program Leadership; Eric A. Hughes, MD, PhD, Head of Global R&D and Chief Medical Officer; and Sophie Lamle, SVP, Head of Innovative Medicines – to discuss the importance of diversity, innovation, and everything in between. Read the full story here: https://ow.ly/G1UV50UygVK #Tevapharm #ClinicalDevelopment #HealthcareInnovation

On both sides of the Atlantic pharma companies are presenting cases to the courts and to national regulators that the innovation cash pipelines will be disrupted, forcing them to either cut back and delay launches or move operations to Asia Pacific or Latin America. Find out more in our detailed whitepaper featuring industry experts: • Christoph Glaetzer, Chief Global Value and Access at Johnson & Johnson Innovative Medicine • Ricardo Marek, President Europe & Canada at Takeda • Andy Powrie-Smith, Executive Director, Communications & Partnerships at EFPIA Access the full whitepaper here: https://bit.ly/3VenKDG

On both sides of the Atlantic pharma companies are presenting cases to the courts and to national regulators that the innovation cash pipelines will be disrupted, forcing them to either cut back and delay launches or move operations to Asia Pacific or Latin America. Find out more in our detailed whitepaper featuring industry experts: • Christoph Glaetzer, Chief Global Value and Access at Johnson & Johnson Innovative Medicine • Ricardo Marek, President Europe & Canada at Takeda • Andy Powrie-Smith, Executive Director, Communications & Partnerships at EFPIA Access the full whitepaper here: https://bit.ly/3VenKDG

On both sides of the Atlantic pharma companies are presenting cases to the courts and to national regulators that the innovation cash pipelines will be disrupted, forcing them to either cut back and delay launches or move operations to Asia Pacific or Latin America. Find out more in our detailed whitepaper featuring industry experts: • Christoph Glaetzer, Chief Global Value and Access at Johnson & Johnson Innovative Medicine • Ricardo Marek, President Europe & Canada at Takeda • Andy Powrie-Smith, Executive Director, Communications & Partnerships at EFPIA Access the full whitepaper here: https://bit.ly/3VenKDG

On both sides of the Atlantic pharma companies are presenting cases to the courts and to national regulators that the innovation cash pipelines will be disrupted, forcing them to either cut back and delay launches or move operations to Asia Pacific or Latin America. Find out more in our detailed whitepaper featuring industry experts: • Christoph Glaetzer, Chief Global Value and Access at Johnson & Johnson Innovative Medicine • Ricardo Marek, President Europe & Canada at Takeda • Andy Powrie-Smith, Executive Director, Communications & Partnerships at EFPIA Access the full whitepaper here: https://bit.ly/3VenKDG

Celebrating Leadership and Innovation at Teva As we embrace Teva’s new business strategy, the commercial SLT team of Teva in Bulgaria put a dedicated focus on the power of our new leadership principles in steering our company towards success. 🤝We were hosted by our colleagues from Teva Dupnitsa production plant where Innovation meets Tradition. This year, the plant celebrates its 70th anniversary, we honor a legacy of excellence that has significantly contributed to the Bulgarian pharmaceutical industry and Teva’s global manufacturing prowess. The plant’s history is a testament to the professionalism and dedication that runs deep within our company’s DNA. 🚀 Teva“Pivot to Growth” strategy is built on four pillars designed to propel Teva into a future of growth and innovation. By accelerating our innovative medicines portfolio, expanding our pipeline, sustaining our generics powerhouse, and focusing on high-impact areas, we’re setting the stage for a healthier tomorrow. 🤝 We, as leaders, believe that Unity and Collaboration success at Teva is a collective effort. It’s about putting the enterprise first and fostering collaboration across all facets of our business. Our teams are inspired and motivated, working together to surpass our business targets and make a meaningful impact. 💡 Our new leadership principles are more than guidelines; they’re a call to action. We lead with integrity and accountability, ensuring every decision aligns with our mission to improve patient health worldwide. 🤝Our commitment to humility, clarity, and ambition is not just a mantra but the foundation of our transformative journey. Let’s continue to build bridges, inspire each other and uphold the values that make Teva a leader in healthcare. Here’s to many more years of making a difference! #tevabulgaria #Leadership #Innovation #Healthcare #PivotToGrowth #Teamwork

Celebrating Leadership and Innovation at Teva As we embrace Teva’s new business strategy, the commercial SLT team of Teva in Bulgaria put a dedicated focus on the power of our new leadership principles in steering our company towards success. 🤝We were hosted by our colleagues from Teva Dupnitsa production plant where Innovation meets Tradition. This year, the plant celebrates its 70th anniversary, we honor a legacy of excellence that has significantly contributed to the Bulgarian pharmaceutical industry and Teva’s global manufacturing prowess. The plant’s history is a testament to the professionalism and dedication that runs deep within our company’s DNA. 🚀 Teva“Pivot to Growth” strategy is built on four pillars designed to propel Teva into a future of growth and innovation. By accelerating our innovative medicines portfolio, expanding our pipeline, sustaining our generics powerhouse, and focusing on high-impact areas, we’re setting the stage for a healthier tomorrow. 🤝 We, as leaders, believe that Unity and Collaboration success at Teva is a collective effort. It’s about putting the enterprise first and fostering collaboration across all facets of our business. Our teams are inspired and motivated, working together to surpass our business targets and make a meaningful impact. 💡 Our new leadership principles are more than guidelines; they’re a call to action. We lead with integrity and accountability, ensuring every decision aligns with our mission to improve patient health worldwide. 🤝Our commitment to humility, clarity, and ambition is not just a mantra but the foundation of our transformative journey. Let’s continue to build bridges, inspire each other and uphold the values that make Teva a leader in healthcare. Here’s to many more years of making a difference! #tevabulgaria #Leadership #Innovation #Healthcare #PivotToGrowth #Teamwork

Celebrating Leadership and Innovation at Teva As we embrace Teva’s new business strategy, the commercial SLT team of Teva in Bulgaria put a dedicated focus on the power of our new leadership principles in steering our company towards success. 🤝We were hosted by our colleagues from Teva Dupnitsa production plant where Innovation meets Tradition. This year, the plant celebrates its 70th anniversary, we honor a legacy of excellence that has significantly contributed to the Bulgarian pharmaceutical industry and Teva’s global manufacturing prowess. The plant’s history is a testament to the professionalism and dedication that runs deep within our company’s DNA. 🚀 Teva“Pivot to Growth” strategy is built on four pillars designed to propel Teva into a future of growth and innovation. By accelerating our innovative medicines portfolio, expanding our pipeline, sustaining our generics powerhouse, and focusing on high-impact areas, we’re setting the stage for a healthier tomorrow. 🤝 We, as leaders, believe that Unity and Collaboration success at Teva is a collective effort. It’s about putting the enterprise first and fostering collaboration across all facets of our business. Our teams are inspired and motivated, working together to surpass our business targets and make a meaningful impact. 💡 Our new leadership principles are more than guidelines; they’re a call to action. We lead with integrity and accountability, ensuring every decision aligns with our mission to improve patient health worldwide. 🤝Our commitment to humility, clarity, and ambition is not just a mantra but the foundation of our transformative journey. Let’s continue to build bridges, inspire each other and uphold the values that make Teva a leader in healthcare. Here’s to many more years of making a difference! #tevabulgaria #Leadership #Innovation #Healthcare #PivotToGrowth #Teamwork

Celebrating Leadership and Innovation at Teva As we embrace Teva’s new business strategy, the commercial SLT team of Teva in Bulgaria put a dedicated focus on the power of our new leadership principles in steering our company towards success. 🤝We were hosted by our colleagues from Teva Dupnitsa production plant where Innovation meets Tradition. This year, the plant celebrates its 70th anniversary, we honor a legacy of excellence that has significantly contributed to the Bulgarian pharmaceutical industry and Teva’s global manufacturing prowess. The plant’s history is a testament to the professionalism and dedication that runs deep within our company’s DNA. 🚀 Teva“Pivot to Growth” strategy is built on four pillars designed to propel Teva into a future of growth and innovation. By accelerating our innovative medicines portfolio, expanding our pipeline, sustaining our generics powerhouse, and focusing on high-impact areas, we’re setting the stage for a healthier tomorrow. 🤝 We, as leaders, believe that Unity and Collaboration success at Teva is a collective effort. It’s about putting the enterprise first and fostering collaboration across all facets of our business. Our teams are inspired and motivated, working together to surpass our business targets and make a meaningful impact. 💡 Our new leadership principles are more than guidelines; they’re a call to action. We lead with integrity and accountability, ensuring every decision aligns with our mission to improve patient health worldwide. 🤝Our commitment to humility, clarity, and ambition is not just a mantra but the foundation of our transformative journey. Let’s continue to build bridges, inspire each other and uphold the values that make Teva a leader in healthcare. Here’s to many more years of making a difference! #tevabulgaria #Leadership #Innovation #Healthcare #PivotToGrowth #Teamwork